19 October 2026
Sidley Represents Aquestive Therapeutics in Exclusive U.S. Licensing Agreement With Eton Pharmaceuticals
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jennifer Raab Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Yuhan Wu | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Jonathan P. Trang | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Steven Przesmicki | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Aquestive Therapeutics, Inc.Sell-side
- Counterparties
- Eton Pharmaceuticals, Inc. (Buy-side)